Weronika Wanat

Ms. Weronika Wanat

Wroclaw University of Science and Technology
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2019 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
WWWeronika Wanat
Weronika Wanat
MTMichal Talma
Michal Talma
MPMałgorzata Pawełczak
Małgorzata Pawełczak
Paweł KafarskiPaweł Kafarski
Paweł Kafarski
The inhibitory activity of 14 racemic phosphonic acid analogs of phenylglycine, substituted in aromatic rings, towards porcine aminopeptidase N (pAPN) and barley seed aminopeptidase was determined experimentally. The obtained patterns of the inhibitory activity against the two enzymes were similar. The obtained data served as a basis for studying the binding modes of these inhibitors by pAPN using molecular modeling. It was found that their aminophosphonate fragments were bound in a highly uniform manner and that the difference in their affinities most likely resulted from the mode of substitution of their phenyl rings. The obtained binding modes towards pAPN were compared, with these predicted for bovine lens leucine aminopeptidase (blLAP) and tomato acidic leucine aminopeptidase (tLAPA). The performed studies indicated that the binding manner of the phenylglycine analogs to biLAP and tLAPA are significantly similar and differ slightly from that predicted for pAPN.

9 April 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
WWWeronika Wanat
Weronika Wanat
MTMichal Talma
Michal Talma
BDBłażej Dziuk
Błażej Dziuk
JPJean-Luc Michel Pirat
Jean-Luc Michel Pirat
Paweł KafarskiPaweł Kafarski
Paweł Kafarski
A library of phosphonic acid analogs of phenylalanine substituted with fluorine, chlorine and trifluoromethyl moieties on the aromatic ring was synthesized and evaluated for inhibitory activity against human (hAPN) and porcine (pAPN) aminopeptidases. Fluorogenic screening indicated that these analogs are micromolar or submicromolar inhibitors, both enzymes being more active against hAPN. In order to better understand the mode of the action of the most active compounds, molecular modeling was used. It confirmed that aminophosphonic portion of the enzyme is bound nearly identically in the case of all the studied compounds, whereas the difference in activity results from the placement of aromatic side chain of an inhibitor. Interestingly, both enantiomers of the individual compounds are usually bound quite similarly.

19 April 2022 in Molecules
Verified
Journal Article
Open access
PDF file
PLPaweł Lenartowicz
Paweł Lenartowicz
MBMaarten Beelen
Maarten Beelen
MMMaciej Makowski
Maciej Makowski
WWWeronika Wanat
Weronika Wanat
BDBłażej Dziuk
Błażej Dziuk
Paweł KafarskiPaweł Kafarski
Paweł Kafarski
The incorporation of dehydroamino acid or fragments of oxazole into peptide chain is accompanied by a distorted three-dimensional structure and additionally enables the introduction of non-typical side-chain substituents. Thus, such compounds could be building blocks for obtaining novel foldamers and/or artificial enzymes (artzymes). In this paper, effective synthetic procedures leading to such building blocks—tetrapeptides containing glycyldehydroalanine, glycyldehydrophenylalanine, and glycyloxazole subunits—are described. Peptides containing serine were used as substrates for their conversion into peptides containing dehydroalanine and aminomethyloxazole-4-carboxylic acid while considering possible requirements for the introduction of these fragments into long-chain peptides at the last steps of synthesis.

14 September 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
WWWeronika Wanat
Weronika Wanat
MTMichal Talma
Michal Talma
BDBłażej Dziuk
Błażej Dziuk
Paweł KafarskiPaweł Kafarski
Paweł Kafarski
A library of novel phosphonic acid analogues of homophenylalanine and phenylalanine, containing fluorine and bromine atoms in the phenyl ring, have been synthesized. Their inhibitory properties against two important alanine aminopeptidases, of human (hAPN, CD13) and porcine (pAPN) origin, were evaluated. Enzymatic studies and comparison with literature data indicated the higher inhibitory potential of the homophenylalanine over phenylalanine derivatives towards both enzymes. Their inhibition constants were in the submicromolar range for hAPN and the micromolar range for pAPN, with 1-amino-3-(3-fluorophenyl) propylphosphonic acid (compound 15c) being one of the best low-molecular inhibitors of both enzymes. To the best of our knowledge, P1 homophenylalanine analogues are the most active inhibitors of the APN among phosphonic and phosphinic derivatives described in the literature. Therefore, they constitute interesting building blocks for the further design of chemically more complex inhibitors. Based on molecular modeling simulations and SAR (structure-activity relationship) analysis, the optimal architecture of enzyme-inhibitor complexes for hAPN and pAPN were determined.

23 January 2020 in Structural Chemistry
Verified
Journal Article
Closed access
PDF file
WWWeronika Wanat
Weronika Wanat
BDBłażej Dziuk
Błażej Dziuk
PKPaweł Kafarski
Paweł Kafarski

27 February 2020 in Structural Chemistry
Verified
Journal Article
Closed access
PDF file
WWWeronika Wanat
Weronika Wanat
BDBłażej Dziuk
Błażej Dziuk
PKPaweł Kafarski
Paweł Kafarski